# The role of α2-agonists in neurosurgery

@article{Cormack2005TheRO,
title={The role of $\alpha$2-agonists in neurosurgery},
author={J. D. Cormack and R M Orme and T G Costello},
journal={Journal of Clinical Neuroscience},
year={2005},
volume={12},
pages={375-378}
}
• Published 1 May 2005
• Medicine
• Journal of Clinical Neuroscience
Summary α 2 -agonists have been extensively used and studied in anaesthesia and intensive care medicine. A list of benefits includes anxiolysis, blood pressure stabilization, analgesia, anaesthetic sparing effects and sedation without respiratory depression or significant cognitive impairment. Fear of inadvertent hypotension, bradycardia or post-operative sedation, and the variability of the haemodynamic response to different doses or rates of administration, have meant that universal…

## Topics from this paper

Off-label Drugs in Perioperative Medicine: Clonidine
• Medicine
• 2011
Clonidine has been widely used for >35 years to treat hypertension, and off-label for a variety of purposes, including withdrawal from long-term abuse of drugs or alcohol, as well as to reduce perioperative stress in patients who are at risk ofperioperative ischaemia and are in chronic pain therapy.
Neuroprotection by dexmedetomidine
• Medicine
• 2006
The current understanding of DEX-mediated neuroprotection is outlined, and this state of knowledge is compared with key criteria for the design of a clinical trial by experts in the field of anaesthetic neuroprotection.
Dexmedetomidine Improves Cardiovascular and Ventilatory Outcomes in Critically Ill Patients: Basic and Clinical Approaches
Evidence supporting the use of dexmedetomidine in different settings is shown from its use in animal models of ischemia-reperfusion, and cardioprotective signaling pathways, and by a group of Chilean pharmacologists and clinicians who have worked for more than 10 years on DEX.
The Perioperative Management of Pain from Intracranial Surgery
• Medicine
Neurocritical care
• 2009
Although pain following intracranial surgery appears to be more intense than initially believed, it is readily treated safely and effectively with techniques that have proven useful following other types of surgery, including patient-controlled administration of opioids.
Dexmedetomidine in Modern Neuroanesthesia Practice
• Current Anesthesiology Reports
• 2021
The purpose of this review is to discuss the role of dexmedetomidine in various procedures in clinical neurosciences. It also gives an overview of the various neurosurgical procedures where
Dexmedetomidine effects in different experimental sepsis in vivo models.
Overall results show evidence that DEX may decrease mortality and inhibit inflammation, as it enhances the activity of the immune system while reducing its systemic reaction and lowering cytokine concentrations.
A randomized controlled study to compare the effectiveness of intravenous dexmedetomidine with placebo to attenuate the haemodynamic and neuroendocrine responses to fixation of skull pin head holder for craniotomy
• Medicine
• 2016
It is demonstrated that, a single bolus dose of dexmedetomidine before induction of anesthesia attenuated the hemodynamic and neuroendocrinal responses to skull-pin insertion in patients undergoing craniotomy.
The effect of dexmedetomidine on cerebral perfusion and oxygenation in healthy piglets with normal and lowered blood pressure anaesthetized with propofol-remifentanil total intravenous anaesthesia
This study investigates the effect of dexmedetomidine on CPO in piglets with normal and lowered blood pressure during background anaesthesia with propofol-remifentanil TIVA and results show a significant decrease in cerebral oxygenation measurements in Piglets with lowering blood pressure.
Dexmedetomidine: A Review of a Newer Sedative in Dentistry.
• Medicine
The Journal of clinical pediatric dentistry
• 2015
The study revealed that Dexmedetomidine being a new drug with its added advantages makes a better choice for sedation in dentistry, but with limited studies on DexmedETomidine, the recommendation to use the drug exclusively is still under debate.
Dexmedetomidine Attenuates the Hemodynamic and Neuroendocrinal Responses to Skull-pin Head-holder Application During Craniotomy
• Medicine
Journal of neurosurgical anesthesiology
• 2008
The results suggested that, a single bolus dose of dexmedetomidine before induction of anesthesia attenuated the hemodynamic and neuroendocrinal responses to skull-pin insertion in patients undergoing craniotomy.

## References

SHOWING 1-10 OF 70 REFERENCES
• Medicine
Acta anaesthesiologica Scandinavica
• 1993
Clonidine, a centrally acting antihypertensive agent, has attracted increasing interest as an adjunct to anaesthesia and the prospect of using specific antagonists to reverse the effects induced by a,adrenergic receptors adds to the attractiveness of this approach.
Alpha‐2 and imidazoline receptor agonistsTheir pharmacology and therapeutic role
• Z. P. Khan, R. M. Jones
• Medicine
Anaesthesia
• 1999
The more selective alpha‐2 adrenoceptor agonists, dexmedetomidine and mivazerol, may also have a role in providing haemodynamic stability in patients who are at risk of peri‐operative ischaemia.
• Biology
• 1995
This work has cloned and designated three human α2-adrenoceptor subtype genes, corresponding to the previously identified pharmacological receptor subtypes α2A, α2C and α2B, and identified some structurally and functionally important domains that are very well conserved.
Intramuscular dexmedetomidine, a novel alpha2‐ adrenoceptor agonist, as premedication for minor gynaecological surgery
• Medicine
Acta anaesthesiologica Scandinavica
• 1991
The haemodynamic as well as the sedative effects of dexmedetomidine after surgery lasted until the end of the observation period, 4 h after the injection of the drug, indicating that intramuscular administration of this premedication agent may result in a longer than optimal duration of pharmacological actions in connection with short surgical procedures.
Effect of Dexmedetomidine, a Selective and Potent α2‐Agonist, on Cerebral Blood Flow and Oxygen Consumption During Halothane Anesthesia in Dogs
• Medicine
Anesthesia and analgesia
• 1990
The cerebral vasoconstrictive effect, combined with the 90% reduction in MAC for halothane, indicates that dexmedetomidine might be a useful adjunct to inhalation anesthetics during neurosurgery in situations where an increase in CBF should be avoided.
Intracranial pressure effects of dexmedetomidine in rabbits.
• Medicine
Anesthesia and analgesia
• 1992
The alpha 2-adrenergic receptor agonist dexmedetomidine produces an anesthetic state in a variety of species and was associated with a 14% decrease in sagittal sinus blood flow that was not statistically significant in these experiments.
Dexmedetomidine, an α2‐Adrenergic Agonist, Decreases Cerebral Blood Flow in the Isoflurane‐Anesthetized Dog
• Medicine
Anesthesia and analgesia
• 1990
10 μg/kg of dexmedetomidine in isoflurane-anesthetized dogs is associated with a profound decrease in CBF and cardiac output in the face of an unaltered CMRo2, and there was no evidence of global cerebral ischemia.
Cardiovascular and endocrine effects of clonidine premedication in neurosurgical patients
• Medicine